NASDAQ · FPHAX
Fidelity Select Pharmaceuticals
Public company research
$33.90
Down-$0.32 (-0.94%)
Updated Sep 11, 2026, 10:06 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.12B
- P/E ratio
- —
- Dividend yield
- 5.58%
- 52-week range
- — – —
- Volume
- 0
- Avg. volume
- 0
Price performance
FPHAX price history
1M range · 0 trading sessions · Daily adjusted prices
FPHAX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest FPHAX news
The latest Smart Investors Daily articles mentioning FPHAX.
Stock researchCompany · Overview
FPHAX research
Overview
Company profile and research snapshot.
Company profile
The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
